lobbying_activities: 2073090

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2073090	adbb4bf1-c92c-46b7-ad1b-80fd978b7a7b	Q4	THE SMITH-FREE GROUP, LLC	35800	BALLANTYNE BRANDS LLC	2017	fourth_quarter	TOB	H.R. 1136, FDA Deeming Authority Clarification Act of 2017 (All sections of full text) Discussions regarding the FDA Proposed Rule, Clarification of When Products Made or Derived from Tobacco Are Regulated as Drugs, Devices, or Combination Productions; Amendments to Regulations Regarding "Intended Uses" (All Sections of full text) Discussions regarding the FDA Implementation of P.L.1111-31 (All sections of full text)	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-01-19T13:42:32.237000-05:00